# Esmolol Effects on Heart and Inflammation in Septic Shock

> **NCT02068287** · PHASE2 · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 25 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT02068287
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2016-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068287, "Esmolol Effects on Heart and Inflammation in Septic Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02068287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*